Nuveen California Municipal Value Fund 2 of Beneficial Interest (NCB) to Issue Monthly Dividend of $0.06 on November 1st

Nuveen California Municipal Value Fund 2 of Beneficial Interest (NYSE:NCB) announced a monthly dividend on Tuesday, October 3rd, Wall Street Journal reports. Investors of record on Friday, October 13th will be paid a dividend of 0.059 per share on Wednesday, November 1st. This represents a $0.71 dividend on an annualized basis and a dividend yield of 4.04%. The ex-dividend date is Thursday, October 12th.

Nuveen California Municipal Value Fund 2 of Beneficial Interest has increased its dividend by an average of 7.3% per year over the last three years.

Shares of Nuveen California Municipal Value Fund 2 of Beneficial Interest (NCB) opened at 17.51 on Wednesday. The company’s 50 day moving average is $17.81 and its 200-day moving average is $17.50. Nuveen California Municipal Value Fund 2 of Beneficial Interest has a 52 week low of $15.73 and a 52 week high of $18.40.

TRADEMARK VIOLATION WARNING: “Nuveen California Municipal Value Fund 2 of Beneficial Interest (NCB) to Issue Monthly Dividend of $0.06 on November 1st” was published by Week Herald and is the property of of Week Herald. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://weekherald.com/2017/10/11/nuveen-california-municipal-value-fund-2-of-beneficial-interest-ncb-to-issue-monthly-dividend-of-0-06-on-november-1st.html.

Dividend History for Nuveen California Municipal Value Fund 2 of Beneficial Interest (NYSE:NCB)

Receive News & Ratings for Nuveen California Municipal Value Fund 2 of Beneficial Interest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuveen California Municipal Value Fund 2 of Beneficial Interest and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply